Search Results
Dr. Scott Solomon: Dapagliflozin Benefits Patients With Heart Failure and Kidney Disease
DELIVER Results - Scott D. Solomon, MD
HF 2022: DELIVER Extends Benefits of Dapagliflozin to the Full Spectrum of Pts with HF
HFA 23: Dapagliflozin and Peripheral Arterial Disease in Heart Failure
What are the results of using Dapagliflozin?
DELIVERing the Details on Dapagliflozin in Heart Failure
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction NEJM
Further research studies of Dapagliflozin
ACC 23: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF
Nurse Webinars - SGLT2i - Dapagliflozin and Empagliflozin
Who should receive Dapagliflozin?
Cardiovascular and renal outcomes with dapagliflozin in people with chronic kidney disease
